Visgeneer (4197) - Total Liabilities

Latest as of June 2026: NT$130.36 Million TWD ≈ $4.11 Million USD

Based on the latest financial reports, Visgeneer (4197) has total liabilities worth NT$130.36 Million TWD (≈ $4.11 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Visgeneer liquidity resilience to evaluate the company's liquid asset resilience ratio.

Visgeneer - Total Liabilities Trend (2011–2025)

This chart illustrates how Visgeneer's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 4197 total assets.

Visgeneer Competitors by Total Liabilities

The table below lists competitors of Visgeneer ranked by their total liabilities.

Company	Country	Total Liabilities
Nuvotec KQ:060260	Korea	₩32.17 Billion
XTL Biopharmaceuticals Ltd ADR NASDAQ:XTLB	USA	$3.12 Million
BRADDA HEAD LITHIUM O.N. F:8CD1	Germany	€73.64K
ChargePanel AB ST:CHARGE	Sweden	Skr8.62 Million
Winfarm PA:ALWF	France	€57.66 Million
Euro Manganese Inc V:EMN	Canada	CA$34.22 Million
Bengal Energy Ltd TO:BNG	Canada	CA$6.88 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Visgeneer's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 4197 equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.45	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.68	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.40	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Visgeneer's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Visgeneer (2011–2025)

The table below shows the annual total liabilities of Visgeneer from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	NT$135.94 Million ≈ $4.28 Million	-1.67%
2024-12-31	NT$138.25 Million ≈ $4.36 Million	-25.51%
2023-12-31	NT$185.60 Million ≈ $5.85 Million	-27.38%
2022-12-31	NT$255.58 Million ≈ $8.05 Million	+22.74%
2021-12-31	NT$208.23 Million ≈ $6.56 Million	-14.65%
2020-12-31	NT$243.97 Million ≈ $7.69 Million	-7.37%
2019-12-31	NT$263.37 Million ≈ $8.30 Million	+30.32%
2018-12-31	NT$202.09 Million ≈ $6.37 Million	-24.20%
2017-12-31	NT$266.61 Million ≈ $8.40 Million	+28.32%
2016-12-31	NT$207.76 Million ≈ $6.55 Million	-7.10%
2015-12-31	NT$223.64 Million ≈ $7.05 Million	+218.59%
2014-12-31	NT$70.20 Million ≈ $2.21 Million	+50.02%
2013-12-31	NT$46.79 Million ≈ $1.47 Million	+45.00%
2012-12-31	NT$32.27 Million ≈ $1.02 Million	+21.13%
2011-12-31	NT$26.64 Million ≈ $839.34K	--

About Visgeneer

TWO:4197 Taiwan Biotechnology

Market Cap

$8.79 Million

NT$278.87 Million TWD

Market Cap Rank

#27482 Global

#1585 in Taiwan

Share Price

NT$9.24

Change (1 day)

+0.54%

52-Week Range

NT$8.10 - NT$19.00

All Time High

NT$28.80